Tower Research Capital (TRC)’s DNA X Inc SONM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.31K | Sell |
642
-19
| -3% | -$84 | ﹤0.01% | 4550 |
|
|
2026
Q1 | $2.66K | Buy |
+661
| New | +$3.12K | ﹤0.01% | 4438 |
|
|
2025
Q4 | – | Sell |
-78
| Closed | -$847 | – | 5560 |
|
|
2025
Q3 | $847 | Sell |
78
-56
| -42% | -$649 | ﹤0.01% | 4926 |
|
|
2025
Q2 | $2.94K | Buy |
134
+14
| +12% | +$345 | ﹤0.01% | 4574 |
|
|
2025
Q1 | $4.61K | Buy |
120
+105
| +700% | +$5.01K | ﹤0.01% | 4229 |
|
|
2024
Q4 | $864 | Buy |
+15
| New | +$896 | ﹤0.01% | 5146 |
|
|
2024
Q3 | – | Sell |
-56
| Closed | -$10.1K | – | 5967 |
|
|
2024
Q2 | $10.1K | Sell |
56
-37
| -40% | -$4.03K | ﹤0.01% | 4179 |
|
|
2024
Q1 | $10.2K | Buy |
93
+16
| +21% | +$1.97K | ﹤0.01% | 3736 |
|
|
2023
Q4 | $10.2K | Buy |
77
+6
| +8% | +$796 | ﹤0.01% | 4283 |
|
|
2023
Q3 | $8.56K | Buy |
71
+32
| +82% | +$4.46K | ﹤0.01% | 4328 |
|
|
2023
Q2 | $8.1K | Buy |
39
+36
| +1,200% | +$7.03K | ﹤0.01% | 4477 |
|
|
2023
Q1 | $0 | Buy |
+3
| New | +$282 | ﹤0.01% | 6251 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6343 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6450 |
|
|
2022
Q2 | – | Sell |
-41
| Closed | -$4.63K | – | 6489 |
|
|
2022
Q1 | $6K | Buy |
41
+1
| +3% | +$135 | ﹤0.01% | 4926 |
|
|
2021
Q4 | $7K | Sell |
40
-27
| -40% | -$8.2K | ﹤0.01% | 4941 |
|
|
2021
Q3 | $32K | Buy |
+67
| New | +$50.9K | ﹤0.01% | 3325 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5817 |
|
|
2021
Q1 | – | Sell |
-4
| Closed | -$7.05K | – | 5698 |
|
|
2020
Q4 | $5K | Sell |
4
-5
| -56% | -$5.46K | ﹤0.01% | 4640 |
|
|
2020
Q3 | $13K | Buy |
9
+8
| +800% | +$12.9K | ﹤0.01% | 4000 |
|
|
2020
Q2 | $2K | Sell |
1
-4
| -80% | -$6.39K | ﹤0.01% | 4536 |
|
|
2020
Q1 | $6K | Hold |
5
| – | – | ﹤0.01% | 2249 |
|
|
2019
Q4 | $33K | Buy |
5
+2
| +67% | +$9.87K | ﹤0.01% | 1607 |
|
|
2019
Q3 | $14K | Sell |
3
-5
| -63% | -$76.7K | ﹤0.01% | 2734 |
|
|
2019
Q2 | $175K | Buy |
+8
| New | +$203K | 0.01% | 914 |
|
Other funds holding SONM
CWM
VCM
VFT
SS
Tower Research Capital (TRC)'s SONM Position: Q2 2026 in Review
Tower Research Capital (TRC) reduced its DNA X Inc (SONM) stake by 2.9% in Q2 2026, selling an estimated $84 and leaving 642 shares worth $3.31K. The position accounts for ﹤0.01% of the portfolio, ranked #4550.
Tower Research Capital (TRC) first reported a position in SONM in Q2 2019 and has held it in 22 quarters since. The position peaked at $175K in Q2 2019. 8 funds tracked by Wall St. Rank hold SONM as of Q2 2026.
- Tower Research Capital (TRC) held 642 shares of DNA X Inc worth $3.31K as of Q2 2026.
- Tower Research Capital (TRC) sold 19 DNA X Inc shares in Q2 2026, an estimated $84.
- DNA X Inc made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4550 holding.
- Tower Research Capital (TRC) first reported a position in DNA X Inc in Q2 2019 and has held it in 22 quarters since.
- Tower Research Capital (TRC)'s DNA X Inc position peaked at $175K in Q2 2019.
- 8 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.